Skip to Content

Novaccess Global Inc XSNX

Morningstar Rating
$0.02 0.00 (21.47%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

XSNX is trading at a 44% discount.
Price
$0.02
Fair Value
$4.14
Uncertainty
Extreme
1-Star Price
$4.65
5-Star Price
$4.27
Economic Moat
Flcxkgk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XSNX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.02
Day Range
$0.020.03
52-Week Range
$0.010.24
Bid/Ask
$0.02 / $0.03
Market Cap
$544,614.26
Volume/Avg
118,502 / 244,580

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body’s defense against cancer.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees

Valuation

Metric
XSNX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
XSNX

Financial Strength

Metric
XSNX
Quick Ratio
0.00
Current Ratio
0.01
Interest Coverage
−2.86
Quick Ratio
XSNX

Profitability

Metric
XSNX
Return on Assets (Normalized)
−2,459.48%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
XSNX
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRGynq$550.4 Bil
VRTX
Vertex Pharmaceuticals IncTbjzh$111.8 Bil
REGN
Regeneron Pharmaceuticals IncVbsxgg$107.9 Bil
MRNA
Moderna IncMmbqh$36.3 Bil
ARGX
argenx SE ADRPtbb$23.0 Bil
BNTX
BioNTech SE ADRHlhd$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncBrrvzl$19.2 Bil
BMRN
Biomarin Pharmaceutical IncNbsjnbg$16.4 Bil
RPRX
Royalty Pharma PLC Class ATylrxp$13.4 Bil
INCY
Incyte CorpMxhnjqp$13.3 Bil

Sponsor Center